| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |